Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Sarah A. Holstein; Fotis Asimakopoulos; Abdel Kareem Azab; Giada Bianchi; Manisha Bhutani; Leslie A. Crews; Tom Cupedo; Hannah Giles; Sarah Gooding; Jens Hillengass; Lukas John; Shari Kaiser; Lydia Lee; Kylee Maclachlan; Marcelo C. Pasquini; Flavia Pichiorri; Nina Shah; Monica Shokeen; Brian R. Shy; Eric L. Smith; Raluca Verona; Saad Z. Usmani; Philip L. McCarthy

doi:10.1016/j.jtct.2022.05.019

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Sarah A. Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, Giada Bianchi, Manisha Bhutani, Leslie A. Crews, Tom Cupedo, Hannah Giles, Sarah Gooding, Jens Hillengass, Lukas John, Shari Kaiser, Lydia Lee, Kylee Maclachlan, Marcelo C. Pasquini, Flavia Pichiorri, Nina Shah, Monica Shokeen, Brian R. Shy, Eric L. SmithRaluca Verona, Saad Z. Usmani, Philip L. McCarthy

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.

Original language	English (US)
Pages (from-to)	446-454
Number of pages	9
Journal	Transplantation and Cellular Therapy
Volume	28
Issue number	8
DOIs	https://doi.org/10.1016/j.jtct.2022.05.019
State	Published - Aug 2022
Externally published	Yes

Keywords

CAR T cell
Imaging
Multiple myeloma
Resistance
Tumor microenvironment

ASJC Scopus subject areas

Immunology and Allergy
Molecular Medicine
Hematology
Cell Biology
Transplantation

Access to Document

10.1016/j.jtct.2022.05.019

Cite this

Holstein, S. A., Asimakopoulos, F., Azab, A. K., Bianchi, G., Bhutani, M., Crews, L. A., Cupedo, T., Giles, H., Gooding, S., Hillengass, J., John, L., Kaiser, S., Lee, L., Maclachlan, K., Pasquini, M. C., Pichiorri, F., Shah, N., Shokeen, M., Shy, B. R., ... McCarthy, P. L. (2022). Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma. Transplantation and Cellular Therapy, 28(8), 446-454. https://doi.org/10.1016/j.jtct.2022.05.019

Holstein, SA, Asimakopoulos, F, Azab, AK, Bianchi, G, Bhutani, M, Crews, LA, Cupedo, T, Giles, H, Gooding, S, Hillengass, J, John, L, Kaiser, S, Lee, L, Maclachlan, K, Pasquini, MC, Pichiorri, F, Shah, N, Shokeen, M, Shy, BR, Smith, EL, Verona, R, Usmani, SZ & McCarthy, PL 2022, 'Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma', Transplantation and Cellular Therapy, vol. 28, no. 8, pp. 446-454. https://doi.org/10.1016/j.jtct.2022.05.019

@article{6d0ae2dbddfb4e83928d35c5f2cb0b17,

title = "Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma",

abstract = "The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.",

keywords = "CAR T cell, Imaging, Multiple myeloma, Resistance, Tumor microenvironment",

author = "Holstein, {Sarah A.} and Fotis Asimakopoulos and Azab, {Abdel Kareem} and Giada Bianchi and Manisha Bhutani and Crews, {Leslie A.} and Tom Cupedo and Hannah Giles and Sarah Gooding and Jens Hillengass and Lukas John and Shari Kaiser and Lydia Lee and Kylee Maclachlan and Pasquini, {Marcelo C.} and Flavia Pichiorri and Nina Shah and Monica Shokeen and Shy, {Brian R.} and Smith, {Eric L.} and Raluca Verona and Usmani, {Saad Z.} and McCarthy, {Philip L.}",

note = "Publisher Copyright: {\textcopyright} 2022 The American Society for Transplantation and Cellular Therapy",

year = "2022",

month = aug,

doi = "10.1016/j.jtct.2022.05.019",

language = "English (US)",

volume = "28",

pages = "446--454",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6375",

publisher = "Elsevier BV",

number = "8",

}

TY - JOUR

T1 - Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

AU - Holstein, Sarah A.

AU - Asimakopoulos, Fotis

AU - Azab, Abdel Kareem

AU - Bianchi, Giada

AU - Bhutani, Manisha

AU - Crews, Leslie A.

AU - Cupedo, Tom

AU - Giles, Hannah

AU - Gooding, Sarah

AU - Hillengass, Jens

AU - John, Lukas

AU - Kaiser, Shari

AU - Lee, Lydia

AU - Maclachlan, Kylee

AU - Pasquini, Marcelo C.

AU - Pichiorri, Flavia

AU - Shah, Nina

AU - Shokeen, Monica

AU - Shy, Brian R.

AU - Smith, Eric L.

AU - Verona, Raluca

AU - Usmani, Saad Z.

AU - McCarthy, Philip L.

PY - 2022/8

Y1 - 2022/8

N2 - The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.

AB - The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup conducted a workshop on Immune and Cellular Therapy in Multiple Myeloma on January 7, 2022. This workshop included presentations by basic, translational, and clinical researchers with expertise in plasma cell dyscrasias. Four main topics were discussed: platforms for myeloma disease evaluation, insights into pathophysiology, therapeutic target and resistance mechanisms, and cellular therapy for multiple myeloma. Here we provide a comprehensive summary of these workshop presentations.

KW - CAR T cell

KW - Imaging

KW - Multiple myeloma

KW - Resistance

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85132893113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132893113&partnerID=8YFLogxK

U2 - 10.1016/j.jtct.2022.05.019

DO - 10.1016/j.jtct.2022.05.019

M3 - Article

C2 - 35605882

AN - SCOPUS:85132893113

SN - 2666-6375

VL - 28

SP - 446

EP - 454

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 8

ER -

Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this